Evidence map›Paper›PMID 42870044›Full record

ArticleNature immunology2026

A unique and equity-driven approach to immunology education in low- and middle-income countries.

Yanet Valdez Tejeira, Gabriela Zamora-Herrera, Monica L Guzman, Sawsan Feki, Roslyn A Kemp, Rosana Pelayo, Clive M Gray, Dieter Kabelitz, Michelle Letarte

Abstract read
PubMed Publisher
In one paragraph

Article in Nature immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yanet Valdez TejeiraIndependent consultant, Vancouver, British Columbia, Canada. yanet.valdeztejeira@fulbrightmail.org.ORCID http://orcid.org/0009-0009-7005-9714
Gabriela Zamora-HerreraInstituto de Fisiología, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico.ORCID http://orcid.org/0000-0002-5571-679X
Monica L GuzmanDivision of Hematology/Medical Oncology, Department of Medicine, Sandra & Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Sawsan FekiImmunology Department, Habib Bourguiba Hospital, Faculty of Medicine of Sfax, University of Sfax, Sfax, Tunisia.ORCID http://orcid.org/0000-0002-5382-5968
Roslyn A KempDepartment of Microbiology and Immunology, University of Otago, Dunedin, Aotearoa New Zealand.ORCID http://orcid.org/0000-0001-9092-1150
Rosana PelayoHealth Education and Research Unit, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Clive M GrayDivision of Immunology, Biomedical Research Institute, Stellenbosch University, Cape Town, South Africa.
Dieter KabelitzInstitute of Medical Immunology, University of Kiel, Kiel, Germany.ORCID http://orcid.org/0000-0002-4160-7103
Michelle LetarteHospital for Sick Children and University of Toronto, Toronto, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42870044

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.